Diarrhea can occur, sometimes alternating with constipation during the adjustment period
Cardiac failure is characterized by myocardial infarction (MI), ventricular systolic dysfunction, and reduced cardiac muscle contraction along with the flow of blood (Roan et al., 1982)
Approved by the FDA in 2017, Ozempic and Wegovy has shown promise not only in controlling blood glucose but also in aiding weight loss, which is a significant advantage given the common association of obesity with type 2 diabetes
Shared decision-making between patient and provider should weigh the medication's benefits against the burden of gastrointestinal adverse effects, exploring whether alternative GLP-1 receptor agonists or different therapeutic approaches might be better tolerated
Clinically, GLP-1 RAs were initially approved for type 2 diabetes mellitus (T2DM) management, demonstrating durable glycemic control and cardiovascular risk reduction in trials ( [3] )
Immuohistochemical score of matrix metalloproteinase-1 may indicate the severity of symptomatic cervical and lumbar disc degeneration
